Rapid HIV type 1 testing of women presenting in late pregnancy with unknown HIV status in Lima, Perú

AIDS Research and Human Retroviruses

Volumn 20, Issue 10, 2004, Pages 1046-1052

  Melvin, Ann J ^a,e   Alarcon, Jorge ^b   Velasquez, Carlos ^c   Rodriguez, Carlos ^c   Piscoya, Julia ^b   Giraldo, Arturo ^b   Dinh, Phillip ^d   Frenkel, Lisa M ^a,d  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b Universidad Nacional Mayor de San Marcos   (Peru)

^c INSTITUTO NACIONAL MATERNO PERINATAL   (Peru)

^d UNIVERSITY OF WASHINGTON   (United States)

^e SEATTLE CHILDREN S RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY;

ADOLESCENT; ADULT; ANTIBODY DETECTION; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; DELIVERY; DIAGNOSTIC TEST; DIAGNOSTIC VALUE; EMERGENCY WARD; ENZYME IMMUNOASSAY; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; PATIENT COUNSELING; PERU; PREGNANCY COMPLICATION; PRIORITY JOURNAL; SCHOOL CHILD; SERODIAGNOSIS; VERTICAL TRANSMISSION; VIRUS TRANSMISSION;

ADOLESCENT; ADULT; AIDS SERODIAGNOSIS; ANTI-HIV AGENTS; CHILD; DELIVERY, OBSTETRIC; DISEASE TRANSMISSION, VERTICAL; FEMALE; HIV ANTIBODIES; HIV INFECTIONS; HIV-1; HUMANS; INFANT, NEWBORN; MIDDLE AGED; PERU; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PRENATAL CARE; TIME FACTORS;

EID: 6344268952     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/aid.2004.20.1046     Document Type: Article

References (18)

1. Lallemant M, Jourdain G, Le Coeur S, et al.: A trial of shortened zidovudine regimens to prevent mother-to-child transmission of human immunodeficiency virus type 1. Perinatal HIV Prevention Trial (Thailand) Investigators. N Engl J Med 2000;343:982-991.
2. Guay LA, Musoke P, Fleming T, et al.: Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial. Lancet 1999;354:795-802.
3. Wade NA, Birkhead GS, Warren BL, et al.: Abbreviated regimens of zidovudine prophylaxis and perinatal transmission of the human immunodeficiency virus. N Engl J Med 1998;339:1409-1414.
4. Alarcon JO, Johnson KM, Courtois B, et al.: Determinants and prevalence of HIV infection in pregnant Peruvian women. AIDS 2003;17:613-618.
5. Centers for Disease Control and Prevention (CDC). Rapid point-of-care testing for HIV-1 during labor and delivery-Chicago, Illinois, 2002. MMWR 2003;52:866-868.
6. Santos BR, Canti IT, Guerin YLS, et al.: Evaluation of an anti-HIV rapid test (Determine/Abbott) offered to pregnant women not tested before delivery in a large public hospital in Porto Alegre, Brazil. 9th Conference on Retroviruses and Opportunistic Infections, February 24-28, 2002, Seattle, WA, #788.
7. Meless H, Tegbaru B, Messele T, et al.: Evaluation of rapid assays for screening and confirming HIV-1 infection in Ethiopia. Ethiopian Med J 2002;40(Suppl. 1):27-36.
8. Branson B, Uniyal A, Kerndt P, Fridlund C, and Granade T: Performance of newer rapid tests for HIV antibody with whole blood and plasma. 9th Conference on Retroviruses and Opportunistic Infections, February 24-28, 2002, Seattle, WA, #599.
9. Van den Berk GEL, Frissen PHJ, Regez RM, and Rietra PM: Evaluation of the rapid immunoassay Determine HIV 1/2 for detection of antibodies for human immunodeficiency virus types 1 and 2. J Clin Microbiol 2003;41:3868-3869.
10. Chalermchockcharoenkit A, Louisirirotchnakul S, Roongpisuthipong A, Sirimai K, Sutchritpongsa P, and Wasi C: Rapid human immunodeficiency virus diagnostic test during the intrapartum period in pregnant women who did not receive antenatal care. J Med Assoc Thai 2002;85:703-708.
11. O'Connell RJ, Merritt TM, Malia JA, et al.: Performance of the OraQuick rapid antibody test for diagnosis of human immunodeficiency virus type 1 infection in patients with various levels of exposure to highly active antiretroviral therapy. J Clin Microbiol 2003;41:2153-2155.
12. Bhore AV, Sastry J, Patke D, et al.: Sensitivity and specificity of rapid HIV testing of pregnant women in India. Int J STD AIDS 2003;14:37-41.
13. UNAIDS/WHO/CDC: Guidelines for appropriate evaluations of HIV testing technologies in Africa. http://www.afro.who.int/aids/laboratory_services/ resources/hiv_test_evaluation_guidelines.pdf.
14. Branson B, Meredith N, Mei J, and Hannon H: How well do rapid HIV tests detect. 9th Conference on Retroviruses and Opportunistic Infections, February 24-28, 2002, Seattle, WA, #361.
15. Guay LA, Musoke P, Fleming T, et al.: Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial. Lancet 1999;354:795-802.
16. Law WP, Dore GJ, Duncombe CJ, et al.: Risk of severe hepatotoxicity associated with antiretroviral therapy in the HIV-NAT Cohort, Thailand, 1996-2001. AIDS 2003;17:2191-2199.
17. Temmerman M, Ndinya-Achola J, Ambani J, and Piot P: The right not to know HIV-test results. Lancet North Am Ed 1995;345:969-970.
18. Malonza IM, Richardson BA, Kreiss JK, Bwayo JJ, and Stewart GC: The effect of rapid HIV-1 testing on uptake of perinatal HIV-1 interventions: A randomized clinical trial. AIDS 2003;17:113-118.